Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

TENAYA THERAPEUTICS, INC.

(TNYA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/13/2021 09/14/2021 09/15/2021 09/16/2021 09/17/2021 Date
22.3(c) 22.97(c) 24.18(c) 24.05(c) 20.85(c) Last
143 730 185 590 200 123 193 093 2 026 021 Volume
-7.47% +3.00% +5.27% -0.54% -13.31% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 - - -
Net income 2021 -67,5 M - -
Net cash position 2021 60,0 M - -
P/E ratio 2021 -1,74x
Yield 2021 -
Sales 2022 - - -
Net income 2022 -95,3 M - -
Net Debt 2022 60,7 M - -
P/E ratio 2022 -2,74x
Yield 2022 -
Capitalization 861 M 861 M -
EV / Sales 2021 -
EV / Sales 2022 -
Nbr of Employees 85
Free-Float 87,4%
More Financials
Company
Tenaya Therapeutics, Inc. is a United States-based biotechnology company. The Company is engaged in the discovering, developing, and delivering therapies that target the underlying causes of heart disease. The Company is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. Its gene therapy... 
More about the company
All news about TENAYA THERAPEUTICS, INC.
09/08TENAYA THERAPEUTICS : Management's Discussion and Analysis of Financial Conditio..
AQ
09/08TENAYA THERAPEUTICS, INC. : Results of Operations and Financial Condition, Finan..
AQ
09/08TENAYA THERAPEUTICS : Reports Second Quarter 2021 Financial Results and Provides..
BU
09/08Tenaya Therapeutics Reports Unaudited Earnings Results for the Second Quarter..
CI
08/31TENAYA THERAPEUTICS : to Present at Morgan Stanley 19th Annual Global Healthcare..
BU
08/24TENAYA THERAPEUTICS : Chardan Starts Tenaya Therapeutics at Buy with $37 Price T..
MT
08/24TENAYA THERAPEUTICS : Cowen Starts Tenaya Therapeutics at Outperform
MT
08/24TENAYA THERAPEUTICS : Morgan Stanley Initiates Coverage on Tenaya Therapeutics W..
MT
08/24TENAYA THERAPEUTICS : Piper Sandler Starts Tenaya Therapeutics at Overweight Wit..
MT
08/09Casdin Capital Engages in Discussions with Tenaya Therapeutics
CI
08/03TENAYA THERAPEUTICS, INC. : Amendments to Articles of Inc. or Bylaws; Change in ..
AQ
08/03TENAYA THERAPEUTICS : Announces Closing of Upsized Initial Public Offering and E..
BU
08/02TENAYA THERAPEUTICS, INC.(NASDAQGS : TNYA) added to NASDAQ Composite Index
CI
07/30TENAYA THERAPEUTICS : Shares Jump in Nasdaq Debut
MT
07/30TENAYA THERAPEUTICS : Prices IPO at $15/Share
MT
More news
News in other languages on TENAYA THERAPEUTICS, INC.

- No features available -

More news
Analyst Recommendations on TENAYA THERAPEUTICS, INC.
More recommendations
Chart TENAYA THERAPEUTICS, INC.
Duration : Period :
Tenaya Therapeutics, Inc. Technical Analysis Chart | TNYA | US87990A1060 | MarketScreener
Technical analysis trends TENAYA THERAPEUTICS, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 20,85 $
Average target price 36,00 $
Spread / Average Target 72,7%
EPS Revisions
Managers and Directors
Faraz Ali Chief Executive Officer, Secretary & Director
Leone D. Patterson Chief Financial Officer & Chief Business Officer
David V. Goeddel Chairman
Timothy Hoey Chief Scientific Officer
Whittemore Tingley Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
TENAYA THERAPEUTICS, INC.0.00%861
MODERNA, INC.311.65%173 588
LONZA GROUP AG32.35%60 074
IQVIA HOLDINGS INC.43.07%49 116
CELLTRION, INC.-23.26%31 904
SEAGEN INC.-10.81%28 420